PCG-PHPCG-PHAMEX

Revenue (LTM)

$24.9B

+2.1% YoY

Net Income (LTM)

$2.7B

+7.6% YoY

Free Cash Flow

$-3.1B

Revenue CAGR (5Y)

+6.2%

Marginsimproving

FCF($3.1B)

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	20,642	21,680↑5.0%	24,428↑12.7%	24,419↓0.0%	24,935↑2.1%
Gross Profit	2,141	2,682↑25.3%	4,002↑49.2%	9,158↑128.8%	4,884↓46.7%
Operating Income	2,141	2,682↑25.3%	4,002↑49.2%	4,459↑11.4%	4,884↑9.5%
Net Income	-88	1,814↑2161.4%	2,256↑24.4%	2,512↑11.3%	2,703↑7.6%
EBITDA	6,269	6,726↑7.3%	7,854↑16.8%	9,935↑26.5%	9,870↓0.7%
EPS Diluted	-0.05	0.84↑1780.0%	1.05↑25.0%	1.15↑9.5%	1.18↑2.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	291	734↑152.2%	635↓13.5%	940↑48.0%	713↓24.1%
Total Current Assets	11,077	12,815↑15.7%	14,383↑12.2%	17,216↑19.7%	15,830↓8.1%
Total Assets	103,327	118,644↑14.8%	125,698↑5.9%	133,660↑6.3%	141,611↑5.9%
Total Current Liabilities	17,427	15,788↓9.4%	17,314↑9.7%	16,330↓5.7%	16,300↓0.2%
Total Liabilities	82,104	95,569↑16.4%	100,406↑5.1%	103,259↑2.8%	108,819↑5.4%
Total Equity	20,971	22,823↑8.8%	25,040↑9.7%	30,149↑20.4%	32,540↑7.9%
Total Debt	46,168	53,539↑16.0%	57,733↑7.8%	58,343↑1.1%	61,335↑5.1%
Net Debt	45,877	52,805↑15.1%	57,098↑8.1%	57,403↑0.5%	60,622↑5.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	2,262	3,721↑64.5%	4,747↑27.6%	8,035↑69.3%	8,716↑8.5%
Capital Expenditure	-7,689	-9,584↓24.6%	-9,714↓1.4%	-10,369↓6.7%	-11,787↓13.7%
Free Cash Flow	-5,427	-5,863↓8.0%	-4,967↑15.3%	-2,334↑53.0%	-3,071↓31.6%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	-320	640↑300.0%	-15↓102.3%	281↑1973.3%	-241↓185.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance